Valeant, others eyeing Pfizer's generics unit: report

14-01-2014 The Globe and MailComments (0)

ActavisGenericsPfizerValeant Pharmaceuticals

Drug makers Valeant Pharmaceuticals International Inc, Actavis Plc and Mylan Inc have all expressed interest in buying Pfizer Inc's branded generics business, but no active discussions are going on at this time, ...

Read more on The Globe and Mail

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top